Skopos Labs, Inc. Eye Point Pharmaceuticals, Inc. Transaction History
Skopos Labs, Inc.
- $330 Million
- Q4 2024
A detailed history of Skopos Labs, Inc. transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 2,578 shares of EYPT stock, worth $18,484. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,578Holding current value
$18,484% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding EYPT
# of Institutions
154Shares Held
58.2MCall Options Held
177KPut Options Held
263K-
Cormorant Asset Management, LP Boston, MA8.33MShares$59.7 Million4.66% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.18MShares$37.1 Million1.63% of portfolio
-
Franklin Resources Inc San Mateo, CA4.01MShares$28.8 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.79MShares$27.2 Million0.06% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$27 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $244M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...